Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Ovarian Cancer
			Peritoneal Cavity Cancer
			Quality of Life
2		Additional conditions recognized in this trial
			Ovarian Neoplasms
3		More general conditions related to this trial
			Adnexal Diseases
			Endocrine Gland Neoplasms
			Endocrine System Diseases
			Genital Diseases, Female
			Genital Neoplasms, Female
			Gonadal Disorders
			Neoplasms
			Neoplasms by Site
			Ovarian Diseases
			Urogenital Neoplasms
4		Interventions listed in this trial
			cisplatin
			paclitaxel
			quality-of-life assessment
5		More general drug interventions related to this trial
			Antimitotic Agents
			Antineoplastic Agents
			Antineoplastic Agents, Phytogenic
			Mitosis Modulators
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Radiation-Sensitizing Agents
			Therapeutic Uses
			Tubulin Modulators
6		Sponsors listed in this trial
			Gynecologic Oncology Group
			National Cancer Institute (NCI)